[BIOA] BioAmber Inc.


Type of security: Stock

Sector: Basic Industries

Industry: Major Chemicals

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.


Price: 4.87 Change: 0.63 (14.91%)
Ext. hours: Change: 0 (0%)

chart BIOA

Refresh chart

Strongest Trends Summary For BIOA

BIOA is in the long-term down -100% below S&P in 9 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to customers in various chemical markets in the United States. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company?s bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, and food additives, as well as anti-freeze solutions, coolants solvents, water treatment chemicals, laundry tablets and bath salts, artificial leather products, and foams made with recycled polyethylene terephthalate. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol, gamma-butyrolactone, and succinic acid based polyesters. The company sells its products directly to its customers and commercial partners, as well as indirectl

Fundamental Ratios
Shares Outstanding EPS-0.41 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -11.57% Sales Growth - Q/Q19.16% P/E-5.88
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-25.16% ROE-52.29% ROI-37.48%
Current Ratio1.21 Quick Ratio1.13 Long Term Debt/Equity6.79 Debt Ratio0.37
Gross Margin-289.61% Operating Margin-2319.63% Net Profit Margin-2329.19% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities11.41 M Cash From Investing Activities-29.47 M Cash From Operating Activities-5.92 M Gross Profit60 K
Net Profit-8.26 M Operating Profit-8.46 M Total Assets144.34 M Total Current Assets30.98 M
Total Current Liabilities25.61 M Total Debt42.57 M Total Liabilities96.75 M Total Revenue370 K
Technical Data
High 52 week2.79 Low 52 week0.03 Last close0.03 Last change-12.09%
RSI40.34 Average true range0.01 Beta0.73 Volume319.26 K
Simple moving average 20 days-6.41% Simple moving average 50 days-25.47% Simple moving average 200 days-93.23%
Performance Data
Performance Week14.7% Performance Month-22.89% Performance Quart-92.47% Performance Half-94.07%
Performance Year-98.58% Performance Year-to-date-92% Volatility daily8.83% Volatility weekly19.76%
Volatility monthly40.49% Volatility yearly140.25% Relative Volume302.7% Average Volume3.59 M
New High New Low


2019-12-10 04:27:00 | BioArctic Strengthens its Management Team With Two Strategic Recruitments

2018-10-25 16:05:00 | BioAmber Provides Update on Liquidation Process

2018-10-25 08:31:23 | Eisai and Biogen Announce Presentation of Additional Data From the Phase II Clinical Trial of BAN2401 in Early Alzheimer’s Disease at the 2018 Clinical Trials on Alzheimer’s Disease CTAD Conference

2018-08-31 16:05:00 | BioAmber Provides Update on Liquidation Process & Announces Resignations of Board Members and Officers

2018-08-09 09:00:00 | BioAmber Provides Update on Liquidation Process

2018-07-30 09:00:00 | BioAmber Provides Update on Sales Process

2018-06-18 17:00:00 | BioAmber Receives Favourable Court Ruling and Approval for DIP Financing

2018-06-07 08:30:00 | Special Meeting of Stockholders Suspended and Update on Restructuration Process

2018-05-04 16:00:00 | BioAmber Announces Filing for Stay of Proceedings on Creditors

2018-05-01 08:00:00 | Special Meeting of Stockholders Adjourned to May 18, 2018

2018-03-28 17:15:40 | Edited Transcript of BIOA earnings conference call or presentation 28-Mar-18 12:00pm GMT

2018-03-27 16:06:00 | BioAmber announces webcast of fiscal fourth quarter 2017 financial results

2018-03-27 16:05:00 | BioAmber Inc. Announces Record Revenues for the Fourth Quarter and Year End 2017

2018-03-16 06:30:00 | BioAmber, Inc. to Host Earnings Call

2018-03-15 17:16:00 | BioAmber Delays Filing of Annual Report on Form 10-K and Postpones Earnings Release and Conference Call for Fourth Quarter and Full Year 2017

2018-03-13 08:00:00 | Aqua Concept GmbH Launches coracon® LT EKO, a Performing and Sustainable Heat Transfer Fluid Engineered from BioAmber's Bio Succinic Acid

2018-03-12 16:05:00 | BioAmber Announces Webcast of Fiscal Fourth Quarter 2017 Financial Results

2018-02-26 08:35:00 | BioAmber, Product Development, Financial Review, TSX Issue, Analysts Target

2018-02-16 08:00:00 | BioAmber Inc. Receives Notice of Delisting by TSX

2018-02-13 16:30:00 | BioAmber Inc. Receives Notice of Delisting Review by TSX

2018-02-09 09:31:00 | BioAmber Inc. Announces Registered Direct Offering; Termination of Underwriting Agreement for Previously-Announced Public Offering

2018-02-06 06:15:00 | BioAmber Inc. Announces Pricing of US$10 Million Underwritten Public Offering

2018-02-05 16:19:16 | Is BioAmber Inc NYSE:BIOA A Financially Sound Company?

2018-02-05 16:15:00 | BioAmber Inc. announces underwritten offering

2018-01-29 08:00:00 | Bio-Succinic Acid Demonstrates Substantial Benefits Toward Growth Performance in Animal Feed Commercial Trial

2018-01-26 08:00:00 | BioAmber restructures its credit facility with its senior lenders

2018-01-02 12:39:08 | With A -20.78% Earnings Drop Lately, Did BioAmber Inc NYSE:BIOA Underperform Its Industry?

2017-12-01 08:36:38 | BioAmber, Inc. :BIOA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017

2017-11-21 13:59:09 | Is It Too Late To Buy BioAmber Inc BIOA?

2017-11-11 17:24:58 | Edited Transcript of BIOA earnings conference call or presentation 7-Nov-17 9:30pm GMT

2017-11-07 18:24:16 | BioAmber reports 3Q loss

2017-11-07 16:05:00 | BioAmber Announces Third Quarter 2017 Financial Results

2017-10-27 08:00:00 | BioAmber Announces Webcast of Fiscal Third Quarter 2017 Financial Results

2017-10-24 17:00:00 | BioAmber President and COO Steps Down

2017-10-10 17:19:14 | How Does Investing In BioAmber Inc BIOA Impact Your Portfolio?

2017-09-14 07:30:00 | BioAmber Announces New Chief Executive Officer

2017-09-13 16:30:00 | BioAmber Inc. Receives Notice of Non-Compliance from the NYSE

2017-08-25 11:12:17 | BioAmber, Inc. :BIOA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

2017-08-08 08:05:00 | BioAmber Inc. Announces US$11 Million Underwritten Offering of Common Stock and Warrants

2017-08-07 16:01:00 | BioAmber Inc. Announces Underwritten Offering of Common Stock and Warrants

2017-08-03 22:45:12 | BioAmber reports 2Q loss

2017-08-03 15:49:47 | Edited Transcript of BIOA earnings conference call or presentation 3-Aug-17 12:30pm GMT

2017-08-03 07:00:00 | BioAmber announces record revenues for the second quarter 2017 and purchase of Mitsui equity stake in Sarnia Joint Venture

2017-08-03 06:50:00 | Investor Network: BioAmber, Inc. to Host Earnings Call

2017-08-01 12:15:00 | BioAmber Announces Webcast of Fiscal Second Quarter 2017 Financial Results

2017-06-15 07:05:00 | BioAmber Launches a Pharmaceutical Grade for its Bio-succinic Acid

2017-05-16 15:37:00 | BIOA DEADLINE ALERT: The Law Offices of Vincent Wong Notifies Investors of BioAmber Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 17, 2017 - BIOA

2017-05-16 13:52:00 | Law Offices of Howard G. Smith Reminds BioAmber Inc. Investors of Pending Lawsuit and Upcoming Lead Plaintiff Deadline

2017-05-16 11:10:00 | DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds Investors with Losses to Contact the Firm

2017-05-16 11:06:00 | BIOA ALERT: Rosen Law Firm Reminds BioAmber Inc. Investors of Important May 17 Deadline in First Filed Class Action - BIOA